We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > T1D

News List

IQVIA and JDRF collaborate to improve understanding of Type 1 Diabetes using real world data expresspharma
July 24, 2020
The collaboration will pave the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders.
Diasome Announces New Chairman of Scientific Advisory Board americanpharmaceuticalreview
December 16, 2019
Diasome Pharmaceuticals named Dr. Jeremy Pettus the chairman of the company’s scientific advisory board.
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes drugs
April 17, 2019
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes.
AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes pharmafocusasia
March 07, 2019
AnTolRx, Inc., a private biotechnology company and a leader in immune tolerance, today announced that Pfizer Inc has exercised the option granted under a June 2016 agreement to license an immune...

Previous page 1 2 Next page